ABSTRACT: For decades, carbamazepine (CBZ) has served as a model compound for groups engaged in the study of crystal polymorphism. Despite considerable effort, crystal structures for only three of its four anhydrous forms have previously been determined. Herein, we report the first single crystal X-ray structure of the high temperature modification of CBZ (form I). Form I crystallizes in a triclinic cell (P-1) having four inequivalent molecules with the following lattice parameters: a ¼ 5.1705(6), b ¼ 20.574(2), c ¼ 22.245(2) Å , a ¼ 84.12(4), b ¼ 88.01(4), and g ¼ 85.19(4)8. Furthermore, we compare the physical properties of the four anhydrous polymorphs of CBZ, including the first comprehensive characterization of form IV. Substantial differences are seen among these forms by powder X-ray diffraction, infrared spectroscopy, thermomicroscopy, and differential scanning calorimetry. These data are correlated to their respective crystal structures for the first time. We have found that all polymorphs possess identical strong hydrogen bonding patterns, similar molecular conformations, and stabilities that are within 0.7 kcal/mol of each other. ß
INTRODUCTION
The role of crystal packing in determining many of the important properties of solid materials has led to increased recognition of the phenomenon of crystal polymorphism. [1] [2] [3] [4] [5] For example, the ability of a pharmaceutical to exist as more than one crystalline polymorph, supramolecular isomers that differ only in molecular packing, 4 creates a situation in which one crystal form may have a favorable dissolution rate, equilibrium solubility, and absorption whereas another is an ineffective therapeutic agent. 6 Although the incidence of polymorphism in the Cambridge Structural Database (CSD) is not high, a with only 3% of organic compounds displaying more than one molecular packing arrangement, 3, 7 the phenomenon is quite common in pharmaceutical solids where nearly one-third have true polymorphs. 8 This discrepancy can be explained by the link between effort expended and the number of polymorphs discovered, with more widely studied pharmaceuticals revealing considerably more forms. 9 Investigators have sought to understand the factors contri-buting to polymorphism including hydrogen bonding, molecular size, and conformational flexibility. [10] [11] [12] However, the question of how many polymorphs a particular compound will give rise to cannot be estimated at present.
Carbamazepine (CBZ) (Structure 1), an anticonvulsant used to treat epilepsy and trigeminal neuralgia, has served as a model compound for many groups studying crystal polymorphism. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] This important anticonvulsant has been found to crystallize as four different anhydrous polymorphs, [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] three of which have been structurally characterized by single crystal X-ray diffraction. The first was found to crystallize in a primitive monoclinic cell (form III). 15, 16, 23 This was followed by the structure of the trigonal modification (form II) 22 and recently a C-centered monoclinic polymorph (form IV). 32 A longstanding question in CBZ polymorphism has been the identification of the high temperature modification (form I). Although the structure could not be determined, recent work 28 on this phase found a triclinic cell with a volume of 2389 Å 3 . This implies that there are either four or eight independent molecules in the unit cell, depending on the space group assignment (Z 0 ¼ 4 for P-1 or Z 0 ¼ 8 for P1). This would make the triclinic structure substantially more complex than the other three forms, each of which contains one molecule in the asymmetric unit. Furthermore, a statistical analysis of the CSD (October 2001 version) finds the incidence of structures with Z 0 ¼ 4 in P-1 is 0.37% (188 of 50835 structures) and that there are only nine reported examples of Z 0 ¼ 8 of the 2233 structures in P1 (0.40%).
b Considering the rarity of cells with four or eight asymmetric molecules in the unit cell, further studies of form I were necessary. Furthermore, to study the relationship between the recently prepared form IV and the other CBZ polymorphs, the molecular packing of the triclinic form was of intense interest.
Herein, we report the single crystal X-ray structure of form I (triclinic) of CBZ and compare the physical properties of the four anhydrous polymorphs of this compound, including the first comprehensive characterization of form IV. A structural comparison reveals that the conformation and sense of dimerization remains unchanged among these four modifications, a unique attribute for a highly polymorphic compound. [33] [34] [35] [36] There has been much confusion about the naming of CBZ polymorphs (Table 1 ). In particular, the morphologically similar trigonal and triclinic forms are difficult to distinguish from one another without the aid of powder X-ray diffraction (PXRD) and/or careful differential scanning calorimetry (DSC) analysis. To definitively identify each of the four anhydrous polymorphs of CBZ, we have reexamined the reported data for the anhydrous polymorphs of CBZ in the literature. [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] These were compared with our own set of PXRD, DSC, and infrared (IR) spectroscopy data that are, for the first time, correlated to the crystal structures of each form.
EXPERIMENTAL Materials
Commercial CBZ (99%, powder) was obtained from Sigma (St. Louis, MO), and stored at 58C. Ethanol (USP grade, absolute) was bought from Pharmco Products Inc. (Brookfield, CT). Methanol (ACS grade) was purchased from Fisher Scientific (Pittsburgh, PA). All solvents were used directly. Hydroxypropyl cellulose (powder, M w 60,000) was obtained from Scientific Polymer Products, Inc. (Ontario, NY) and used directly.
Preparation of CBZ Polymorphs
Triclinic CBZ (form I) suitable for single crystal Xray diffraction was prepared from the melt in a vacuum-sealed capillary. The capillary was then heated to 192.08C to ensure complete melting of the compound and the temperature decreased to 183.58C at a rate of 8.08C/min. At this temperature, nucleation occurred within minutes forming triclinic crystals suitable for analysis by single crystal X-ray diffraction. Bulk form I was obtained by heating 0.3 g of commercial CBZ or recrystallized P-monoclinic at 1508C for 3 h. The difficulty associated with determination of structures with more than one molecule in the asymmetric unit will lower their frequency in the CSD below their natural occurrence rate.
STRUCTURE OF CARBAMAZEPINE
Trigonal CBZ (form II) was prepared by dissolving 0.96 g of commercial CBZ in 20 mL of ethanol at 808C. The solution was slowly cooled to room temperature and then cooled further to 58C for 5 h. The needles were collected by filtration and dried under reduced pressure. P-monoclinic CBZ (form III) was crystallized by slow evaporation of an ethanol solution (16.5 mg/mL) at room temperature. C-monoclinic CBZ (form IV) crystallization was performed by slow evaporation of methanol solutions (16.5 mg/mL) at room temperature in the presence of hydroxypropyl cellulose. 32, 37 Seeding of supersaturated methanol solutions (155 mg/ mL) at room temperature also produced form IV. Crystals were harvested 10 h after the seed crystal was added.
Single Crystal X-ray Diffraction
Single crystal X-ray diffraction data of the triclinic form of CBZ was recorded on a Bruker SMART CCD-based X-ray diffractometer equipped with an LT-2 low temperature device and MoKa source (l ¼ 0.71073 Å ). The structure was solved and refined using the Bruker SHELXTL (version 5.10) software package. All non-hydrogen atoms were refined anisotropically with the hydrogen atoms located on a difference Fourier map and allowed to refine independently.
PXRD
PXRD data were recorded at room temperature on a Bruker AXS D 8 Advance powder diffractometer at 40 kV, 40 mA with a CuKa source (l ¼ 1.5406 Å ) between 3 and 908 2y with a scan speed of 0.2 s/ step and a step size of 0.0388. Samples, ground into powders with an agate mortar and pestle, were measured on a low background quartz plate in an aluminum holder.
Fourier Transform Infrared Spectroscopy (FTIR)
FTIR spectra were recorded on a Perkin-Elmer Spectrum BX FTIR system, equipped with a deuterium triglycine sulfate detector. The scan range was 600-4000 cm À1 , using eight scans per spectrum with a resolution of 1 cm À1 . Spectra were obtained in the transmission mode in KBr pellets. Spectra were also taken of pure crystalline samples using IR microscopy to compare the effects of grinding and pressure on the samples. A Perkin-Elmer Spectrum GX FTIR system, These forms are most similar to C-monoclinic CBZ, however, differences noted in the text exist.
equipped with an Auto IMAGE system camera and microscope, was used to collect the IR microscopy spectra.
Thermomicroscopy
Thermomicroscopy was performed with a Mettler Toledo FP82HT hot stage connected to an FP 90 control processor and viewed under polarized light with a Leica DMLP microscope. Samples of each of the four polymorphs were heated from 50 to 2008C at a rate of 108C/min for initial observation. Upon viewing thermal transformations in forms II, III, and IV, each of these was converted completely and the samples were then removed from the hot stage and identified using PXRD.
DSC
Thermograms of the samples were recorded on a Perkin-Elmer DSC 7 connected to a Perkin-Elmer TAC 7/DX thermal analysis controller with Pyris software (version 3.81). Samples (2-3 mg weighed to a precision of 0.005 mg) were placed in aluminum pans and the lids were crimped using a Perkin-Elmer crimper. Thermal behavior of the samples was studied under a nitrogen purge at various heating rates, covering a temperature range of 30-2108C. The instrument was calibrated with an indium standard.
RESULTS AND DISCUSSION
Single Crystal X-ray Diffraction
Single crystal X-ray analysis of form I at 158(2) K revealed a triclinic lattice: (4), and g ¼ 85.
19 (4)8. This confirmed the lattice parameters previously determined, 28 with the expected volume contraction from low temperature collection.
c The asymmetric unit consists of four molecules (Fig. 1 ) that each form hydrogen-bonded anti dimers through the carboxamide donor and carbonyl acceptor as in the other three modifications of the drug. Graph set analysis 38, 39 revealed that these are R2,2(8) dimers. However, only two dimers are centrosymmetric, formed between identical residues (Fig. 2) , whereas the other unique dimer is pseudocentrosymmetric and consists of inequivalent 1,3 residue pairs, where the two NÀHÁÁÁO hydrogen bonds differ by <0.1 Å .
For comparative conformational analysis, each of the four inequivalent molecules of form I and also those of the other three forms were computationally overlaid using the OFIT function of XP Interactive Molecular Graphics (version 5.10, Bruker AXS). The largest root mean square deviation between atomic positions among these four forms was <0.15 Å , as observed in the overlay fits of individual molecules. Furthermore, because all forms exist as dimers in the solid state, all inequivalent R2,2(8) dimer pairs of the four forms were overlaid and displayed <0.40 Å root mean square deviation, demonstrating a consistent sense of conformation and dimerization throughout the four forms with regard to their strong hydrogen bonding network. This stands in contrast to conformational polymorphism or changes in strong hydrogen bonding networks which are observed in other tetramorphic or higher order polymorphic systems: sulfapyridine, pyrazincarboxamide, sulfathiazole, and 5-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile. [33] [34] [35] [36] Thus, CBZ is an excellent example of crystal polymorphism in which conformation and strong hydrogen-bonding scheme remains constant throughout all of its forms.
The differences among crystal forms lie solely in the packing of the carboxamide dimer units. This can be described by the pattern of weak CÀHÁÁÁO interactions (<2.60 Å from the normalized, 1.083 Å for CÀH, position of the hydrogen), which are prevalent throughout all of the four forms (Fig. 2) , using graph sets. 38, 39 Both monoclinic forms have similar, yet distinct interactions and the trigonal and triclinic forms are also structurally related. The monoclinic forms both have infinite C(7) chains through a vinylic hydrogen of the azepine ring and an oxygen acceptor. The CÀHÁÁÁO bonds that link the dimer units of both monoclinic forms have lengths of 2.48 and 2.28 Å for forms III and IV, respectively. The two polymorphs with needle morphologies, triclinic and trigonal, are strikingly similar in their weak hydrogen bond patterns. In both structures, each oxygen acts as an acceptor to hydrogens from two nearby carbons. The position of the carbon donors is identical in both forms: one is ortho to the urea from an identical residue in an adjacent unit cell and the other is para to the urea from the nearest donor residue. Perhaps because of the high symmetry of the trigonal system, there is only one significant pattern of weak hydrogen bonding. This is a C1,2(6) chain that spirals about the needle axis of the crystal.
d These spirals are all linked to each other through the R2,2(8) dimer units, thus creating an infinite network. The triclinic form has similar spiral chains about its needle axis. However, because the spirals involve three inequivalent molecules (residues 2, 3, and 4) they are termed C3,6(24) chains. Also present in the triclinic structure are R2,4(20) rings involving residues 1 and 3. These rings along with the R2,2(8) dimer rings link the spiral chains causing d The needle axes of both triclinic and trigonal were determined using BFDH morphology prediction as implemented in Cerius an extended three-dimensional network similar to that of the trigonal form.
Nomenclature of CBZ Polymorphs
From Table 1 it is obvious that there is inconsistency in the naming of CBZ polymorphs, leading to confusion and the misidentification of forms. The conclusions presented here are based on careful comparison of simulated PXRD patterns to our experimental diffraction data. These are then correlated to DSC thermograms, IR spectra, and methods of preparation of each form and compared with the data of the previous investigators.
We note that there was a previous attempt to clarify the CBZ nomenclature in which the authors identified one of their forms as being trigonal based on literature references. 24 However, it is actually the triclinic form they present. This form was produced by heating P-monoclinic, which is well known to produce triclinic CBZ.
14,17-19,21,26-28,30,31 However, this occurred several years before the elucidation of the triclinic lattice. 28 Because the trigonal and triclinic forms are morphologically similar, without extreme care in analyzing PXRD patterns and precise DSC measurements, [17] [18] [19] differentiating these forms is not a trivial task.
There have been two previous reports of the existence of four CBZ polymorphs. 13, 19 One indicates the presence of four forms of CBZ based on thermomicroscopy. 13 These forms are identified by their melting points, with the highest melting modification termed form I and the next highest as form II, etc. Because melting points are dependent on heating rates it is difficult to conclude which forms were being observed. Furthermore, other characterization methods are not offered and thus comparisons with other preparations cannot be made. More extensive data are provided in another report of four anhydrous polymorphs of CBZ. 19 However, forms II and IV are deemed the same based on peak positions and intensities of the PXRD diffractograms. There are three peaks lacking in the form II PXRD pattern, which are likely a product of preferred orientation of the trigonal form because they are present in simulated and our experimental PXRD patterns. Furthermore, it has been previously suggested that a mixture of modifications 21 would account for differences these authors observed in the IR spectra. Thus, only three anhydrous polymorphs were identified rather than the four reported. By contrast, a polymorph prepared by dehydration, 21, 31 designated by the authors as form II, has several characteristics of C-monoclinic prepared in our lab. The published PXRD, DSC, and IR data for the dehydrated form most closely resembles Cmonoclinic CBZ. However, discrepancies in the carbonyl stretching frequency in the IR spectrum 21 and the appearance of an amorphous impurity in the DSC 31 indicates the material described is not in pure form and no structural data is offered.
PXRD
The most reliable way to distinguish the four polymorphs of CBZ is with PXRD (Fig. 3) Table 2 . These values compare well with simulated PXRD patterns in terms of 2y positions with the expected small shifts resulting from the different temperatures of data collection. However, the intensities vary, especially for forms I and II, because of preferred orientation of samples in the powder X-ray experiment.
FTIR Spectroscopy
The three main regions for identifying and distinguishing the polymorphs of CBZ are 3500-3392, 1731-1629, and 1427-1317 cm À1 (Fig. 4,  Table 3 ). IR microscopy of single crystals of each form and KBr pellets produced at 10,000 psi yielded very similar spectra indicating that a phase transformation under grinding and pressure was not taking place in any of the forms. In form I, absorptions occur at 3485, 1688, and 1396 cm À1 . Similarly, these peaks are at 3485, 1690, and 1395 cm À1 for form II and at 3466, 1677, and 1386 cm À1 in form III. The above values are in good agreement with those reported in the literature. 14, 22, 31 In form IV, the corresponding peaks are at 3474, 1674, and 1394 with a small shoulder at 1418 cm À1 . The spectrum of form IV also shows a double peak at 773 and 765 cm À1 , where only a single peak occurs at this position for the other three forms. These peaks differ by as many as 16 cm À1 among forms making them particularly diagnostic. However, the triclinic and trigonal spectra are nearly identical in peak positions across the entire spectrum with variations of <3 cm À1 . This provides additional evidence for the structural similarity of the two forms and complicates distinguishing the trigonal and triclinic forms based on IR spectra. However, IR spectroscopy has the potential to be a fast, reliable method of polymorph characterization provided that extreme care is exercised in analyzing the data.
Thermomicroscopy
The overall thermal behavior of the four CBZ polymorphs during the heating process was viewed on a hot stage under polarized light at a rate of 108C/ min. Form I showed no transformations and 
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One The following experiments were performed to explicitly identify which form each of the three polymorphs (II-IV) had transitioned to upon heating. Form II was heated to 1608C and held at this temperature for 10 min to ensure complete conversion. Form III was heated to 1828C at 108C/min, where complete melting and crystallization occurred during the heating process. Form IV was heated to 1878C and held at this temperature for 5 min to make certain that melting and crystallization to the new form were completed. All samples were cooled to room temperature and subjected to PXRD to identify the resulting form. This revealed that all polymorphs of CBZ transform to form I upon heating.
DSC
The thermograms for the C-monoclinic form IV differed significantly from those of the other three forms of CBZ (Figs. 5 and 6 ). DSC curves recorded at 208C/min showed two endothermic peaks, a large peak at 187.7(1)8C followed by a small peak at 191.5(2)8C. The first endothermic peak corresponds to the melting of form IV and the second endothermic peak, similar to this phenomenon in form III, corresponds to the melting of crystallized form I. The DSC trace of form IV depends on the analytical heating rate. A decrease in scan rate results in a reduction in melting point and a more complete transformation to form I (Fig. 6 ). This causes a decrease in the first endotherm of melting corresponding to form IV and an increase in the second endotherm of melting corresponding to form I. The DSC thermogram for the P-monoclinic form III, recorded at 208C/min, exhibited two endotherms and one exotherm (Fig. 5) . The first endothermic peak was at 174.8(12)8C, followed immediately by an exothermic peak and subsequently a second endothermic peak at 193.2(2)8C. Thermomicroscopy showed that form III melted and subsequently crystallized to form I from 168 to 1758C, which was confirmed by the use of PXRD as mentioned above. Thus, the first endothermic peak on the DSC curve corresponds to the melting of form III, the exothermic peak shows the crystallization of form I, and the second endothermic peak coincides to the melting of form I.
The thermogram for the trigonal form II, recorded at 208C/min, showed a small exotherm [À0.35(2) kcal/mol] in the range between 140 and 1608C and one endotherm at 192.1(5)8C (Fig. 5) . The range over which the exotherm is seen on the DSC curve corresponds to the crystal transformation of form II to form I, as observed in thermomicroscopy experiments, and the endothermic peak is consistent with the melting of form I. This transformation, although overlooked by some authors perhaps because of its small enthalpy, is well entrenched in the literature. [17] [18] [19] The DSC curve of the triclinic form I, recorded at 208C/min, showed only one endothermic peak at 193.5(6)8C corresponding to the melting point of this form (Fig. 5) . Scheme 1 summarizes the relationship of the four forms in terms of their thermal behavior and conversion to form I.
DSC revealed the following order of stability of CBZ polymorphs (Table 4) : form III > form I > form IV > form II. This is the expected order based on the density rule, 40 which states: ''If one modification of a molecular crystal has a lower density than the other, it may be assumed to be less stable at absolute zero.'' Thus, the density rule holds though only small differences in energy exist among the four forms. In fact, the energy separation is <0.7 kcal/mol between the most and least stable form, which means that for any computational method to correctly predict the proper order of stability of CBZ polymorphs, it must be accurate to much better than 1 kcal/mol, a rigorous requirement that is seldom met in practice. 41 Also notable is that the most recently characterized polymorph, form IV, 32 is more thermodynamically stable than form II, which was reported decades earlier.
CONCLUSION
With the complete structure of the triclinic polymorph of CBZ in hand, it now joins only two other compounds in the CSD that are tetramorphic. 33, 34 These compounds, along with the sole examples of penta- 36 and hexamorphic 35 systems, define the current limits of structurally characterized organic solid-state isomers. Understanding the factors that give rise to these forms and their interconversion is a major challenge for experiment and theory. Currently, we are studying the thermal transformation of the trigonal form to the triclinic form of CBZ 17, 18 to understand the structural changes occurring in the crystal. 
